Skip to Content
Get key facts and figures about chronic dry eye

Lodoxamide ophthalmic Pregnancy and Breastfeeding Warnings

Lodoxamide ophthalmic is also known as: Alomide

Medically reviewed on December 15, 2017.

Lodoxamide ophthalmic Pregnancy Warnings

Use is not recommended unless clearly needed.

AU TGA pregnancy category: B1
US FDA pregnancy category: B

Animal studies using doses up to 5000 times the normal human dose have failed to reveal evidence of reproductive toxicity. Some manufacturers recommend avoiding use of this drug as a precautionary measure. There are no controlled data in human pregnancy.

AU TGA pregnancy category B1: Drugs which have been taken by only a limited number of pregnant women and women of childbearing age, without an increase in the frequency of malformation or other direct or indirect harmful effects on the human fetus having been observed. Studies in animals have not shown evidence of an increased occurrence of fetal damage.

US FDA pregnancy category B: Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.

See references

Lodoxamide ophthalmic Breastfeeding Warnings

Some manufacturers suggest a risk to the infant cannot be excluded due to insufficient data and therefore recommend use be avoided.

Caution is recommended

Excreted into human milk: Unknown
Excreted into animal milk: Unknown

Comment:
Apply pressure to the tear duct by the corner of the eye for at least 1 minute after eye drop instillation to limit systemic absorption; blot excess solution with tissue.

See references

References for pregnancy information

  1. Cerner Multum, Inc. "Australian Product Information." O 0
  2. "Product Information. Alomide (lodoxamide ophthalmic)." Alcon Laboratories Inc, Fort Worth, TX.
  3. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0

References for breastfeeding information

  1. United States National Library of Medicine "Toxnet. Toxicology Data Network. Available from: URL: http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT." ([cited 2013 -]):
  2. Cerner Multum, Inc. "Australian Product Information." O 0
  3. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
  4. "Product Information. Alomide (lodoxamide ophthalmic)." Alcon Laboratories Inc, Fort Worth, TX.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide